Institutional shares held 25.3 Million
92K calls
161K puts
Total value of holdings $1.23B
$4.46M calls
$7.8M puts
Market Cap $2.02B
41,663,000 Shares Out.
Institutional ownership 60.8%
# of Institutions 123


Latest Institutional Activity in JANX

Top Purchases

Q1 2024
Adage Capital Partners Gp, L.L.C. Shares Held: 2.78M ($135M)
Q1 2024
Rtw Investments, LP Shares Held: 1M ($48.5M)
Q1 2024
Orbimed Advisors LLC Shares Held: 4.28M ($207M)
Q1 2024
Cormorant Asset Management, LP Shares Held: 750K ($36.4M)
Q1 2024
Lord, Abbett & Co. LLC Shares Held: 542K ($26.3M)

Top Sells

Q1 2024
Bvf Inc Shares Held: 2.92M ($142M)
Q1 2024
Citadel Advisors LLC Shares Held: 2.35M ($114M)
Q1 2024
Samsara Bio Capital, LLC Shares Held: 180K ($8.74M)
Q1 2024
Black Rock Inc. Shares Held: 1.69M ($82.2M)
Q1 2024
Millennium Management LLC Shares Held: 5.78K ($281K)

About JANX

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.


Insider Transactions at JANX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
3.09M Shares
From 7 Insiders
Other acquisition or disposition 49K shares
Open market or private purchase 3.04M shares
Sell / Disposition
4.84M Shares
From 4 Insiders
Open market or private sale 3.82M shares
Other acquisition or disposition 1.02M shares

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Track Activities on JANX